Abstract |
The efficient delivery of anticancer drugs into tumor tissues to improve therapeutic efficacy remains an urgent demand. To satisfy this demand, a drug delivery system based on a stealthy nanocapsule was developed. This nanocapsule was fabricated by encapsulating stealthy cross-linked poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) and benzaldehyde groups around the protein bovine serum albumin (BSA) followed by conjugation of doxorubicin (Dox) through a pH-responsive benzoic- imine bond. The in vitro results show that the Dox-conjugated nanocapsule ( nBSA-Dox) released the drug under an acidic tumor microenvironment (pH ~6.5) and killed HepG2 human liver cancer cells. The half-life of Dox conjugated to nBSA in mice was significantly prolonged, and the area-under-curve of plasma Dox of the mice treated with nBSA-Dox was as much as 242 fold of free Dox. The in vivo results confirmed that this nanocapsule efficiently accumulated in tumor tissue and significantly suppressed the tumor growth.
|
Authors | Gan Liu, Hsiang-I Tsai, Xiaowei Zeng, Yixiong Zuo, Wei Tao, Jun Han, Lin Mei |
Journal | Theranostics
(Theranostics)
Vol. 7
Issue 5
Pg. 1192-1203
( 2017)
ISSN: 1838-7640 [Electronic] Australia |
PMID | 28435458
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Drug Carriers
- Nanocapsules
- Phosphorylcholine
- Doxorubicin
|
Topics |
- Animals
- Antibiotics, Antineoplastic
(pharmacokinetics, therapeutic use)
- Cell Survival
(drug effects)
- Disease Models, Animal
- Doxorubicin
(pharmacokinetics, therapeutic use)
- Drug Carriers
(administration & dosage)
- Half-Life
- Hep G2 Cells
- Hepatoblastoma
(drug therapy)
- Hepatocytes
(drug effects, physiology)
- Heterografts
- Humans
- Hydrogen-Ion Concentration
- Mice
- Nanocapsules
(administration & dosage)
- Phosphorylcholine
(administration & dosage)
- Treatment Outcome
- Tumor Microenvironment
|